AP607A - Inhibiting photodecomposition of 3-substituted-2-oxindoles. - Google Patents

Inhibiting photodecomposition of 3-substituted-2-oxindoles. Download PDF

Info

Publication number
AP607A
AP607A APAP/P/1996/000787A AP9600787A AP607A AP 607 A AP607 A AP 607A AP 9600787 A AP9600787 A AP 9600787A AP 607 A AP607 A AP 607A
Authority
AP
ARIPO
Prior art keywords
red
yellow
dye
lake
thienyl
Prior art date
Application number
APAP/P/1996/000787A
Other languages
English (en)
Other versions
AP9600787A0 (en
Inventor
Jr Willard C Newlin
Sharon M Laughlin
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of AP9600787A0 publication Critical patent/AP9600787A0/xx
Application granted granted Critical
Publication of AP607A publication Critical patent/AP607A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4883—Capsule finishing, e.g. dyeing, aromatising, polishing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polymerisation Methods In General (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
APAP/P/1996/000787A 1995-04-24 1996-03-07 Inhibiting photodecomposition of 3-substituted-2-oxindoles. AP607A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB1995/000287 WO1996033701A1 (en) 1995-04-24 1995-04-24 Inhibiting photodecomposition of 3-substituted-2-oxindoles

Publications (2)

Publication Number Publication Date
AP9600787A0 AP9600787A0 (en) 1996-04-30
AP607A true AP607A (en) 1997-08-27

Family

ID=36997502

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/1996/000787A AP607A (en) 1995-04-24 1996-03-07 Inhibiting photodecomposition of 3-substituted-2-oxindoles.

Country Status (30)

Country Link
EP (1) EP0827399A1 (is)
JP (1) JPH10506635A (is)
KR (1) KR100189585B1 (is)
CN (1) CN1053667C (is)
AP (1) AP607A (is)
AR (1) AR002728A1 (is)
AU (1) AU692378B2 (is)
BG (1) BG100531A (is)
BR (1) BR9602024A (is)
CO (1) CO4700418A1 (is)
FI (1) FI973988A0 (is)
HR (1) HRP960194A2 (is)
HU (1) HU216544B (is)
IL (1) IL117969A0 (is)
IS (1) IS4339A (is)
MA (1) MA23848A1 (is)
NO (1) NO961622L (is)
NZ (1) NZ286432A (is)
OA (1) OA10286A (is)
PE (1) PE34397A1 (is)
RO (1) RO113305B1 (is)
RU (1) RU2109510C1 (is)
SG (1) SG64924A1 (is)
SI (1) SI9600133A (is)
SK (1) SK51296A3 (is)
TR (1) TR199600300A2 (is)
UA (1) UA42739C2 (is)
WO (1) WO1996033701A1 (is)
YU (1) YU25096A (is)
ZA (1) ZA963210B (is)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3085172A1 (en) 2017-12-29 2019-07-04 Kraft Foods Group Brands Llc Improved oxidative stability of oil-in-water emulsions using natural stabilizers

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2246072A (en) * 1990-07-20 1992-01-22 Egyt Gyogyszervegyeszeti Gyar Pharmaceutical compositions stabilised against light
WO1994007488A1 (en) * 1992-10-07 1994-04-14 Pfizer Inc. 3-substituted 2-oxindole-1-carboxamide pharmaceutical compositions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3136282A1 (de) * 1981-09-12 1983-03-24 Hoechst Ag "verfahren zur stabilisierung photoinstabiler arzneistoffe sowie stabilisierte arzneizubereitungen"

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2246072A (en) * 1990-07-20 1992-01-22 Egyt Gyogyszervegyeszeti Gyar Pharmaceutical compositions stabilised against light
WO1994007488A1 (en) * 1992-10-07 1994-04-14 Pfizer Inc. 3-substituted 2-oxindole-1-carboxamide pharmaceutical compositions

Also Published As

Publication number Publication date
RU2109510C1 (ru) 1998-04-27
UA42739C2 (uk) 2001-11-15
PE34397A1 (es) 1997-09-29
BR9602024A (pt) 1998-10-06
FI973988L (fi) 1997-10-17
AU5085196A (en) 1996-11-07
JPH10506635A (ja) 1998-06-30
AU692378B2 (en) 1998-06-04
AR002728A1 (es) 1998-04-29
TR199600300A2 (tr) 1996-11-21
CN1139110A (zh) 1997-01-01
KR100189585B1 (ko) 1999-06-01
KR960037656A (ko) 1996-11-19
SG64924A1 (en) 1999-05-25
BG100531A (bg) 1997-06-30
HUP9601057A2 (en) 1997-04-28
NZ286432A (en) 1998-05-27
OA10286A (en) 1997-09-19
HU216544B (hu) 1999-07-28
CN1053667C (zh) 2000-06-21
MA23848A1 (fr) 1996-12-31
EP0827399A1 (en) 1998-03-11
IL117969A0 (en) 1996-08-04
AP9600787A0 (en) 1996-04-30
NO961622L (no) 1996-10-25
CO4700418A1 (es) 1998-12-29
HU9601057D0 (en) 1996-06-28
HRP960194A2 (en) 1998-02-28
NO961622D0 (no) 1996-04-23
WO1996033701A1 (en) 1996-10-31
FI973988A7 (fi) 1997-10-17
SK51296A3 (en) 1997-04-09
YU25096A (sh) 1998-08-14
SI9600133A (en) 1996-10-31
FI973988A0 (fi) 1997-10-17
RO113305B1 (ro) 1998-06-30
ZA963210B (en) 1997-10-23
HUP9601057A3 (en) 1997-05-28
IS4339A (is) 1996-10-25

Similar Documents

Publication Publication Date Title
CA1303504C (en) Pharmaceutical formulation containing acrivastine
AU2003271103B2 (en) Solid preparation
PL181215B1 (pl) Kompozycja farmaceutyczna zawierająca ibuprofen i kodeinę oraz sposób jej wytwarzania
NZ270748A (en) Sustained release dosage form of alfuzosin hydrochloride coated with a ph-dissolution dependent polymer
CA1300509C (en) Pharmaceutical compositions for relief of dysmenorrhea and/orpremenstrual syndrome and process
ATE195073T1 (de) Feste pharmazeutische zubereitung mit (s)-2-(4- isobutylphenyl)propionsäure als wirkstoff und mikrokristalliner cellulose und kolloidalem silica als hilfstoff
NL8600302A (nl) Farmaceutische preparaten met analgetische werkzaamheid, alsmede de bereiding en toepassing ervan.
AP607A (en) Inhibiting photodecomposition of 3-substituted-2-oxindoles.
CA2003478A1 (en) Combination of an hmg coa reductase inhibitor and other type of serum cholesterol reducing agent and method for lowering serum cholesterol using such combination
CA2216931A1 (en) Inhibiting photodecomposition of 3-substituted-2-oxindoles
NL8002041A (nl) Werkwijze voor het bereiden van een analgetisch en myotonolytisch geneesmiddel.
TW577741B (en) Novel pharmaceutical combination for treating pain comprising paracetamol and buspirone
US4188393A (en) Treating spastic conditions or relaxing muscles
EP0444546B1 (en) Hydantoin derivatives for use as hypoglycemic and/or hypolipidemic agents
AU620658B2 (en) Memory-enhancing compositions containing dioxopiperidine derivatives
CN1925857A (zh) 治疗高血脂症的组合物
JPS6323969B2 (is)
HK1080385B (en) Solid preparation
HK1124772B (en) Pharmaceutical preparation having excellent photostability